Biological characterization of CD40-activated B cells as a prerequisite for their use as cellular adjuvant in cancer vaccines

Bibliographic Details
Main Authors: Nadler LM, Fiore F, Maecker B, von Bergwelt-Baildon MS, Schultze JL
Format: Article
Language:English
Published: BMC 2004-07-01
Series:Cancer Cell International